BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

$0.83
+0.02 (+2.50%)
As of Nov 7, 10:59 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +5,281.6% upside
Low Target $28.75
Average Target $44.56
High Target $50.07
Current Price $0.83
Current
$0.83
Target
$44.56
$28.75 $44.56 avg $50.07
Scenario Analysis
Bear Case
$28.75
3,372.2%
Low target
Base Case
$44.56
+5,281.6%
Avg target
Bull Case
$50.07
+5,947.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.66
-50.1% from high
52-Week Low
$0.56
+49.2% from low
Target vs 52W High
$44.56
+2,584.3% vs high
Next Earnings Report
Nov 10, 2026
1d
tomorrow
EPS Est: $-0.22
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%